These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 24288761)
1. Polymeric complexes of isonicotinic acid hydrazide with antituberculosis effects. Slivkin AI; Lapenko VL; Bychuk AI; Suslina SN; Slivkin DA; Kornienko SV; Belenova AS Bull Exp Biol Med; 2013 Oct; 155(6):764-6. PubMed ID: 24288761 [TBL] [Abstract][Full Text] [Related]
2. Experimental data on the antimicrobial activity of Isoprodian (PTH). Urbanczik R Scand J Respir Dis Suppl; 1978; 102():58-9. PubMed ID: 98838 [No Abstract] [Full Text] [Related]
3. Preparation and antitubercular activities in vitro and in vivo of novel Schiff bases of isoniazid. Hearn MJ; Cynamon MH; Chen MF; Coppins R; Davis J; Joo-On Kang H; Noble A; Tu-Sekine B; Terrot MS; Trombino D; Thai M; Webster ER; Wilson R Eur J Med Chem; 2009 Oct; 44(10):4169-78. PubMed ID: 19524330 [TBL] [Abstract][Full Text] [Related]
8. Isoniazid-resistant disseminated Mycobacterium tuberculosis in a Jamaican infant with HIV/AIDS. Singh-Minott I; Pierre RB; Olugbuyi O; Dunkley-Thompson J; Haughton D; Christie CD West Indian Med J; 2008 Jun; 57(3):298-301. PubMed ID: 19583132 [TBL] [Abstract][Full Text] [Related]
9. [Reasons for drug-resistant tuberculosis emergence]. Tu DH Zhonghua Jie He He Hu Xi Za Zhi; 2007 Jun; 30(6):403-5. PubMed ID: 17673006 [No Abstract] [Full Text] [Related]
10. [The influence of the simultaneous administration of 5-bromosalicylohydroxamic acid (T-40) and isonicotinic acid hydrazide on the concentration of free isonicotinic acid hydrazide in the urine of patients with pulmonary tuberculosis]. Zduńczyk-Pawelek H; Otrzonsek N; Kostrzewska K Gruzlica; 1965 May; 33(5):411-5. PubMed ID: 5319220 [No Abstract] [Full Text] [Related]
11. Location of Pulmonary Mycobacteria Tuberculosis and Effectiveness of Various Dextrazide Compositions in Treatment of Mice with BCG-Induced Granulomatosis. Sinyavskaya AM; Shkurupy VA; Troitskiy AV; Kovner AM Bull Exp Biol Med; 2020 May; 169(1):63-66. PubMed ID: 32495171 [TBL] [Abstract][Full Text] [Related]
12. [Evaluation of the efficiency of activity of the liposomal form of isoniazid against different types of mycobacteria in vitro]. Golyshevskaia VI; Selishcheva AA; Martynova LP; Lepekha LN; Kalashnikova TM; Kornilova ZKh; Erokhin VV; Rozenberg OA Probl Tuberk Bolezn Legk; 2006; (8):61-4. PubMed ID: 17002062 [TBL] [Abstract][Full Text] [Related]
19. Structure-based design of some isonicotinic acid hydrazide analogues as potential antitubercular agents. Atta A; Fahmy S; Rizk O; Sriram D; Mahran MA; Labouta IM Bioorg Chem; 2018 Oct; 80():721-732. PubMed ID: 30077175 [TBL] [Abstract][Full Text] [Related]
20. Evaluation of the potential role of a new mutation in mabA in modifying the response of Mycobacterium tuberculosis to isoniazid. Alonso M; Martínez-Lirola M; Palacios JJ; Menéndez Á; Herranz M; Martínez S; Bouza E; García-de-Viedma D Tuberculosis (Edinb); 2013 Nov; 93(6):664-7. PubMed ID: 23973657 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]